163 related articles for article (PubMed ID: 26844860)
1. Current controversies in traditional and expanded carrier screening.
Lazarin GA; Goldberg JD
Curr Opin Obstet Gynecol; 2016 Apr; 28(2):136-41. PubMed ID: 26844860
[TBL] [Abstract][Full Text] [Related]
2. Carrier testing in children and adolescents.
Vears DF; Metcalfe SA
Eur J Med Genet; 2015 Dec; 58(12):659-67. PubMed ID: 26563495
[TBL] [Abstract][Full Text] [Related]
3. Expanded Carrier Screening.
Gregg AR
Obstet Gynecol Clin North Am; 2018 Mar; 45(1):103-112. PubMed ID: 29428278
[TBL] [Abstract][Full Text] [Related]
4. Expanded carrier screening: A review of early implementation and literature.
Lazarin GA; Haque IS
Semin Perinatol; 2016 Feb; 40(1):29-34. PubMed ID: 26718446
[TBL] [Abstract][Full Text] [Related]
5. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
6. Responsible implementation of expanded carrier screening.
Henneman L; Borry P; Chokoshvili D; Cornel MC; van El CG; Forzano F; Hall A; Howard HC; Janssens S; Kayserili H; Lakeman P; Lucassen A; Metcalfe SA; Vidmar L; de Wert G; Dondorp WJ; Peterlin B
Eur J Hum Genet; 2016 Jun; 24(6):e1-e12. PubMed ID: 26980105
[TBL] [Abstract][Full Text] [Related]
7. Finding Middle Ground in Constructing a Clinically Useful Expanded Carrier Screening Panel.
Stevens B; Krstic N; Jones M; Murphy L; Hoskovec J
Obstet Gynecol; 2017 Aug; 130(2):279-284. PubMed ID: 28697118
[TBL] [Abstract][Full Text] [Related]
8. Ethnicity-Based Carrier Screening.
King JR; Klugman S
Obstet Gynecol Clin North Am; 2018 Mar; 45(1):83-101. PubMed ID: 29428288
[TBL] [Abstract][Full Text] [Related]
9. Prenatal genetic carrier testing using triple disease screening.
Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
[TBL] [Abstract][Full Text] [Related]
10. Variables that underlie cost efficacy of prenatal screening.
Kinzler WL; Morrell K; Vintzileos AM
Obstet Gynecol Clin North Am; 2002 Jun; 29(2):277-86, v-vi. PubMed ID: 12108828
[TBL] [Abstract][Full Text] [Related]
11. Carrier screening for recessive disorders.
Antonarakis SE
Nat Rev Genet; 2019 Sep; 20(9):549-561. PubMed ID: 31142809
[TBL] [Abstract][Full Text] [Related]
12. Genetic Counselors' Perspectives and Practices Regarding Expanded Carrier Screening after Initial Clinical Availability.
Lazarin GA; Detweiler S; Nazareth SB; Ashkinadze E
J Genet Couns; 2016 Apr; 25(2):395-404. PubMed ID: 26354338
[TBL] [Abstract][Full Text] [Related]
13. Recommendations of the European society of human genetics on genetic testing for common disorders.
Field A; Baxter K; Terry SF
Genet Test Mol Biomarkers; 2011 May; 15(5):291-2. PubMed ID: 21561286
[No Abstract] [Full Text] [Related]
14. DNA-based carrier screening in the Ashkenazi Jewish population.
Zhang B; Dearing L; Amos J
Expert Rev Mol Diagn; 2004 May; 4(3):377-92. PubMed ID: 15137904
[TBL] [Abstract][Full Text] [Related]
15. Quality assessment of genetic counseling process in the context of presymptomatic testing for late-onset disorders: a thematic analysis of three review articles.
Paneque M; Sequeiros J; Skirton H
Genet Test Mol Biomarkers; 2012 Jan; 16(1):36-45. PubMed ID: 21819246
[TBL] [Abstract][Full Text] [Related]
16. Expanded carrier screening in reproductive medicine-points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Fetal Medicine.
Edwards JG; Feldman G; Goldberg J; Gregg AR; Norton ME; Rose NC; Schneider A; Stoll K; Wapner R; Watson MS
Obstet Gynecol; 2015 Mar; 125(3):653-662. PubMed ID: 25730230
[TBL] [Abstract][Full Text] [Related]
17. Patients' ratings of genetic conditions validate a taxonomy to simplify decisions about preconception carrier screening via genome sequencing.
Leo MC; McMullen C; Wilfond BS; Lynch FL; Reiss JA; Gilmore MJ; Himes P; Kauffman TL; Davis JV; Jarvik GP; Berg JS; Harding C; Kennedy KA; Simpson DK; Quigley DI; Richards CS; Rope AF; Goddard KA
Am J Med Genet A; 2016 Mar; 170(3):574-82. PubMed ID: 26792268
[TBL] [Abstract][Full Text] [Related]
18. Cystic fibrosis carrier screening in obstetric clinical practice: knowledge, practices, and barriers, a decade after publication of screening guidelines.
Darcy D; Tian L; Taylor J; Schrijver I
Genet Test Mol Biomarkers; 2011; 15(7-8):517-23. PubMed ID: 21453058
[TBL] [Abstract][Full Text] [Related]
19. The evolving landscape of expanded carrier screening: challenges and opportunities.
Kraft SA; Duenas D; Wilfond BS; Goddard KAB
Genet Med; 2019 Apr; 21(4):790-797. PubMed ID: 30245516
[TBL] [Abstract][Full Text] [Related]
20. Knowledge and attitudes regarding expanded genetic carrier screening among women's healthcare providers.
Ready K; Haque IS; Srinivasan BS; Marshall JR
Fertil Steril; 2012 Feb; 97(2):407-13. PubMed ID: 22137493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
